Delving into the Latest Updates on Bone Marrow Derived MSCs therapy(HomeoTherapy) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Action-

Mechanism

Stem cell replacements

Therapeutic Areas

Immune System Diseases

Active Indication-

Inactive Indication

Graft vs Host Disease

Originator Organization

HomeoTherapy Co., Ltd.

Active Organization-

Inactive Organization

HomeoTherapy Co., Ltd.

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

Official Title: Five-Week, Multi-center, Phase I Clinical Trial to Evaluate Safety of Homeo-GH after Intra Venus Administration for the Treatment of Graft versus Host Disease Patients
Sponsor: HomeoTherapy Co.,Ltd
Study Design: Single Group, Open Label, 5 Week, Safety Study
This study is designed to evaluate the safety of ex-vivo cultured adult human clonal mesenchymal stem cells (cMSC) derived from human bone marrow in subjects experiencing acute or chronic graft-versus-host disease (GVHD).
Study Type: Interventional

Start Date01 Nov 2010

Sponsor / Collaborator

HomeoTherapy Co., Ltd.

100 Clinical Results associated with Bone Marrow Derived MSCs therapy(HomeoTherapy)

Login to view more data

100 Translational Medicine associated with Bone Marrow Derived MSCs therapy(HomeoTherapy)

Login to view more data

100 Patents (Medical) associated with Bone Marrow Derived MSCs therapy(HomeoTherapy)

Login to view more data

100 Deals associated with Bone Marrow Derived MSCs therapy(HomeoTherapy)

Login to view more data